Dianhydrogalactitol

DB12873InvestigationalSmall molecule

Dianhydrogalactitol has been used in trials studying the treatment of GBM, Glioma, Glioblastoma, Brain Cancer, and Glioblastoma Multiforme.

Chemical structure of Dianhydrogalactitol
Mechanism
Curator reviewed
Formula / weight
C6H10O4 · 146.142 g/mol (avg)
Also known as
1,2:5,6-Dianhydrogalactitol
Code names
NSC-1323313 · VAL-083

Resolves to

Compound
UNII4S465RYF7MCAS23261-20-3ChEMBLCHEMBL3137322PubChem15942827
Structure
InChIKeyAAFJXZWCNVJTMK-GUCUJZIJSA-NSMILESO[C@@H]([C@@H](O)[C@H]1CO1)[C@@H]1CO1

What you can answer from here — as of October 01, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Dianhydrogalactitol, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In